Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > CEA-Leti and partners developing injectable tracer for diagnosing and operating on tumors

Abstract:
CEA-Leti announced today that it and four French partners are developing an injectable tracer that can provide both nuclear imaging in the pre-operative evaluation of tumors and optical imaging during ablation or biopsy.

CEA-Leti and partners developing injectable tracer for diagnosing and operating on tumors

Grenoble, France | Posted on March 16th, 2011

The three-year Nano-ENO project is developing a specific tracer using a patented organic nano-carrier (Lipidot®). To improve its targeting capacities, a peptide molecule that recognizes certain types of cancer will also be grafted to the Lipidots.

In addition to CEA-Leti, the Nano-ENO project partners are:
- A team from the Frédéric Joliot Hospital in Orsay

- AAA, based in Saint-Genis-Pouilly, and specializing in radiopharmaceutical products

- Fluoptics, a CEA-Leti startup based in Grenoble and specializing in fluorescence-imaging systems, and

- VetAgro Sup, based in Marcy-l'Etoile, will oversee the pre-clinical studies on large- animal model (spontaneous tumors in dogs)

When treating cancer, medical professionals often look to several diagnostic tools and surgical aids, including positron emission tomography (PET) scan and fluorescence imaging. A PET scan is a nuclear-imaging procedure that allows doctors to measure the metabolic activity of an organ by injecting a radiotracer and then analyzing the gamma rays that are emitted as the tracer disintegrates.

Fluorescence imaging is a relatively new technology that combines the use of a florescent tracer with near-infrared spectroscopy (NIRS). The resulting real-time images help surgeons obtain cleaner margins during surgery and therefore reduce the risk of recurrence.

The nuclear markers used in a PET scan help provide high-resolution images, while optical contrast agents facilitate the identification of tumor cells in real-time. Combining these imaging technologies makes it possible to confirm that the tumors being operated on correspond to the tumors identified in the pre-operative studies. It also allows for a more thorough procedure to be performed with reduced overall surgical time; not only can the surgeon work more quickly and with greater precision, but the entire operation is streamlined, allowing for a more efficient use of operating rooms and surgical staff.

This project will receive support from the Cancéropôle Lyon Auvergne Rhône Alpes (CLARA) "Preuve de Concept" (Proof of Concept) initiative for three years.

####

About CEA-Leti
EA is a French research and technology organization, with activities in four main areas: energy, information technologies, healthcare technologies and defence and security. Within CEA, the Laboratory for Electronics & Information Technology (CEA-Leti) works with companies in order to increase their competitiveness through technological innovation and transfers. CEA-Leti is focused on micro and nanotechnologies and their applications, from wireless devices and systems, to biology and healthcare or photonics. Nanoelectronics and microsystems (MEMS) are at the core of its activities. As a major player in MINATEC campus, CEA-Leti operates 8,000-m² state-of-the-art clean rooms, on 24/7 mode, on 200mm and 300mm wafer standards. With 1,200 employees, CEA-Leti trains more than 190 Ph.D. students and hosts 200 assignees from partner companies. Strongly committed to the creation of value for the industry, CEA-Leti puts a strong emphasis on intellectual property and owns more than 1,700 patent families.

About CLARA

In the context of a national cancer action plan, CLARA (Cancéropôle Lyon Auvergne Rhône-Alpes) is a government-funded program supporting cancer research in the Rhône-Alpes and Auvergne regions. It brings together academic, clinical, and commercial interests from both regions to contribute to the fight against cancer on the local, national, and international level. Specifically, CLARA fosters partnerships between the public and private sectors and encourages the exchange of technology. With the goal of helping the most patients, Cancéropôle is working to establish the Rhone-Alpes/Auvergne axis as the European authority in cancer research.

www.canceropole-clara.com

About CLARA’s POC Initiative

In 2005, CLARA decided that private finance initiatives were a logical choice for structuring their partnerships between publically funded laboratories and private industry. The “Preuve de Concept” (Proof of Concept) program was the result of this decision. Today, the POC initiative supports 25 projects and represents a budget of over 32 million Euros (23 million of which is provided by the eighteen commercial partners). Four projects have confirmed status, including one product that is currently being marketed in Europe and the United States (EndoControl’s ViKY® system, an ultra compact robotized endoscope positioner).

For more information, please click here

Contacts:
CEA-Leti
Thierry Bosc
+33 4 38 78 31 95


Patrick Boisseau
+33 4 38 78 38 54


Agency
Amélie Ravier
+33 1 58 18 59 30


sarah-lyle dampoux
account supervisor


loomis::group
www.loomisgroup.com
phone +33 (0)1 58 18 59 30

Copyright © CEA-Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

‘Designer’ nanodevice could improve treatment options for cancer sufferers October 22nd, 2014

Imaging

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014

Chip Technology

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014

Materials for the next generation of electronics and photovoltaics: MacArthur Fellow develops new uses for carbon nanotubes October 21st, 2014

Nitrogen Doped Graphene Characterized by Iranian, Russian, German Scientists October 21st, 2014

Nanomedicine

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Announcements

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Patents/IP/Tech Transfer/Licensing

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

Research partnerships

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Brookhaven Lab Launches Computational Science Initiative:Leveraging computational science expertise and investments across the Laboratory to tackle "big data" challenges October 22nd, 2014

Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014

Nitrogen Doped Graphene Characterized by Iranian, Russian, German Scientists October 21st, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE